Authors
Latest:
Do Antibiotic Adverse Effects Affect Prescribing Practices?A focus group study reviewed provider practices to learn more about patient management and explore the potential to follow up with clinicians on important takeaways.
Latest:
Improving the Diagnosis of Intracardiac InfectionsThis technology is effective in cases that are difficult to diagnose.
Latest:
Invasive Nontyphoidal Salmonellosis: An Antimicrobial-Resistant FoeSalmonella becomes more dangerous as antimicrobial resistance grows. Read about its most common manifestations.
Latest:
Lessons in Resilience: What HIV Teaches Us About COVID-19Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.
Latest:
Final Diagnosis: Donor-Derived Staphylococcus Iugdunensis Endocarditis of Transplanted Heart"This case gives uncomfortable insight into a gap in early detection of infections in immunocompromised, high-risk patient populations. "
Latest:
Cefiderocol’s Role in Managing Carbapenem-Resistant Acinetobacter baumannii InfectionsThis agent is likely best utilized as part of a combination when treating this bacterium but data regarding appropriate combinations are scarce.
Latest:
Pulmonary Coinfection With C neoformans and C immitis: A Novel Fungal CohabitationA patient presented with a history of uncontrolled HIV and a history of polysubstance use.
Latest:
Need for Speed: Rapid Antiretroviral Initiation in the Emergency DepartmentEmergency departments (EDs) are an important entry point into the health care system and have been identified as a location with opportunity for increased HIV diagnosis and management.
Latest:
Improving Screening, Management of Hepatitis C in Infants and ChildrenDespite hepatitis C (HCV) incidence rates increasing, adequate screening for the virus continues to be a pressing challenge for public health officials.
Latest:
Infectious Diseases Provider Role in Extracorporeal Membrane Oxygenation InfectionsThere has been an emergence of extracorporeal membrane oxygenation-associated infections. Here is a review of how to define them and clinical management of this heterogeneous syndrome.
Latest:
Antimicrobial Stewardship Can Help Prevent Injection Drug Use–Related InfectionsEscalating usage and more drug choices are putting more people at risk.
Latest:
World Polio Day: A Time to Reflect on Accomplishments, Acknowledge There’s Still Work to DoCarol Pandak, EdD, director of PolioPlus, Rotary International, discusses the significance of this day and efforts that continue around the world to work towards eradication of this disease.
Latest:
A Day Late and a Dollar Short: Managing Antimicrobial Drug ShortagesWith antimicrobial drug shortages expected to continue globally, developing mitigation strategies is essential to prevent complications, including antimicrobial resistance.
Latest:
Detecting T Cell Dysfunction in Post-Acute Infection SyndromesNigel McCracken, PhD, presents a diagnostic test to identify early T cell dysfunction in syndromes like Long COVID and ME/CFS, aiming to improve treatment strategies before symptoms escalate.
Latest:
Exploring the Recently Approved and Upcoming Clostridioides difficile TherapeuticsThis market has seen a flurry of activity, as shown by a review of the latest agents.
Latest:
The Challenges of Hepatitis B Clinical Care Within Underserved CommunitiesIn the second part of their interview, Debika Bhattacharya, MD MSc, and Su H. Wang, MD, MPH, FACP, continue the conversation around the difficulties of getting people into care, and what the new hepatitis B guidelines hope to improve in this area.
Latest:
2024 S aureus and MRSA Trials: Key TakeawaysJeffrey Freiberg, MD, PhD review of the SABATO trial on oral antibiotics for S aureus bacteremia and a comparison of mupirocin and iodine treatments for MRSA decolonization.
Latest:
Assisting With International Health Care NeedsAlthough the pandemic halted many medical mission assignments, these opportunities and others are becoming available to help those geographic areas with acute needs.
Latest:
Should Cefazolin be Prescribed in Patients With B-lactam Allergies?For patients undergoing surgery, looking at the potential benefits of this antimicrobial for prophylaxis.
Latest:
IMUNON’s IMNN-101 Vaccine Shows Promising Results in Phase 1 Trial, Demonstrates Cross-Reactivity Against COVID VariantsStacy Lindborg, PhD, highlights the vaccine’s immune response, safety, and global distribution potential.
Latest:
Defining the Characteristics of Breakthrough Invasive Fungal Infections in Hematologic DisordersThis systematic review focuses on breakthrough invasive fungal infections (bIFIs) in patients with high-risk hematological cancers, like acute leukemia, or those who have undergone stem cell transplants. Despite prophylactic antifungal treatments (usually with voriconazole or posaconazole), bIFIs remain challenging due to their complexity and high mortality rates.
Latest:
Simplifying Vaccine Access Translates to Better UptakeInvestigators evaluated strategies to simplify the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.
Latest:
Candida auris: Coming Soon to a Facility Near You?Epidemiologic and clinical lessons for the uninitiated.
Latest:
Multidrug Resistance in a Patient With HIVIn this case study, clinicians review a challenging case.
Latest:
The Next Generation of COVID-19 Vaccines and BoostersWill there be an answer to keep the continuously evolving virus at bay? Are seasonal combination vaccines the wave of the future?
Latest:
Funding Isn’t Everything: Bringing Pharma to the Table for the Pasteur ActThe pharmaceutical industry faces challenges when investing in new antibiotics, which emphasizes the need for regulatory reforms, incentives, and collaborative efforts between government, healthcare organizations, and private companies. The prospective bill, the Pasteur Act, is one potential strategy to help in these areas, and incentivize pharmaceutical companies to develop these essential therapies.
Latest:
That’s Not Appropriate: A Look at Antibiotic Prescribing Post DischargeExtending antimicrobial stewardship programs to transition of care and discharge may prove beneficial to reduce unnecessary antibiotic use.
Latest:
Health Equity is Essential to Overcoming Antimicrobial ResistanceThe antimicrobial resistance (AMR) crisis stems from natural microbial adaptation and the lack of new antimicrobials in development. Vulnerable populations worldwide, including within the US, are disproportionately affected, exacerbating the spread of resistance.
Latest:
The Importance to Address and Help Visceral Adiposity in HIV PatientsDavid Wohl, MD, explains the health risks of visceral fat and the role of treatments like Tesamorelin F8 in managing the condition.
